Form 4: Compass Pathways Director George Jay Goldsmith Sells Shares in Private Transaction

Director George Jay Goldsmith sold 776,565 shares of Compass Pathways (CMPS) in a private transaction to Lars Wilde, a former co-founder, on October 24, 2024.

Summary

• George Jay Goldsmith, a director of Compass Pathways plc (CMPS), sold 776,565 Ordinary Shares represented by American Depositary Shares (ADSs) on October 24, 2024.
• The sale was a private transaction to Lars Wilde, a former co-founder of Compass Pathways.
• The transaction was executed pursuant to previously disclosed call option agreements dating back to May 19, 2020, and subsequently amended.
• Wilde exercised his option to purchase the shares at a nominal value per ordinary share.
• Following the transaction, Goldsmith directly owns 3,155,122 Ordinary Shares.
• Goldsmith's spouse, Dr. Ekaterina Malievskaia, indirectly owns 3,152,848 Ordinary Shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a pre-planned sale based on a prior agreement. It doesn't necessarily indicate a positive or negative outlook on the company's future.

Industry Context

This transaction represents a private sale between a company director and a former co-founder, which is not uncommon in the biotech industry. Such transactions can sometimes reflect internal perspectives on the company's value, but in this case, it is tied to a pre-existing agreement.

Comparison to Industry Standards

• Comparing this transaction to similar insider sales in the pharmaceutical industry, the sale of 776,565 shares is a significant but not unusual amount for a director.
• For example, directors at companies like Pfizer or Moderna often trade shares, but these are typically related to stock option exercises or diversification strategies.
• The key difference here is the pre-existing call option agreement, which makes this transaction less discretionary than typical insider sales.

Related Party Transactions

• The sale to Lars Wilde, a former co-founder, constitutes a related-party transaction due to his prior association with the company.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders, as it is a private sale executed under a pre-existing agreement.

Key Dates